| Charles Pritchard, MD | |
|
10901 E 48th St, Tulsa, OK 74146-5830 | |
| (918) 749-8765 | |
| (918) 392-2155 |
| Full Name | Charles Pritchard |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 22 Years |
| Location | 10901 E 48th St, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275654246 | NPI | - | NPPES |
| 200112290A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 25590 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Fort Smith | Fort smith, AR | Hospital |
| Oklahoma Surgical Hospital, Llc | Tulsa, OK | Hospital |
| Mcalester Regional Health Center | Mcalester, OK | Hospital |
| St John Medical Center, Inc | Tulsa, OK | Hospital |
| Ascension St John Broken Arrow | Broken arrow, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcalester Medical Services Llc | 9931139029 | 22 |
| Urologic Specialists Of Oklahoma Inc | 3779470091 | 34 |
| Urologic Specialists Of Oklahoma Inc | 3779470091 | 34 |
News Archive
NovaBay Pharmaceuticals, Inc. today announced that its lead product candidate was safe and efficacious against the highly contagious skin infection impetigo in a Phase 2a proof-of-concept clinical trial. This dose-ranging study showed that the drug cleared impetigo infections, including those in the trial caused by a drug-resistant strain of bacteria called methicillin-resistant Staphylococcus aureus or MRSA. Impetigo afflicts approximately 1 million people, primarily infants and children, in the United States annually.
In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.
For the first time, researchers led by Frank Lau, MD, Assistant Professor of Clinical Surgery at LSU Health New Orleans, have successfully kept white fat tissue alive outside of the body for up to eight weeks.
ChromaDex Corporation ("ChromaDex"), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure®, announced today the completion of the acquisition of Spherix Consulting, Inc., a subsidiary of Spherix, Inc.
Tonja Jimenez is far from the only person driving an RV down Colorado's rural highways. But unlike the other rigs, her 34-foot-long motor home is equipped as an addiction treatment clinic on wheels, bringing lifesaving treatment to the northeastern corner of the state, where patients with substance use disorders are often left to fend for themselves.
› Verified 1 days ago
| Entity Name | Urologic Specialists Of Oklahoma Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174546162 PECOS PAC ID: 3779470091 Enrollment ID: O20040302000514 |
News Archive
NovaBay Pharmaceuticals, Inc. today announced that its lead product candidate was safe and efficacious against the highly contagious skin infection impetigo in a Phase 2a proof-of-concept clinical trial. This dose-ranging study showed that the drug cleared impetigo infections, including those in the trial caused by a drug-resistant strain of bacteria called methicillin-resistant Staphylococcus aureus or MRSA. Impetigo afflicts approximately 1 million people, primarily infants and children, in the United States annually.
In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.
For the first time, researchers led by Frank Lau, MD, Assistant Professor of Clinical Surgery at LSU Health New Orleans, have successfully kept white fat tissue alive outside of the body for up to eight weeks.
ChromaDex Corporation ("ChromaDex"), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure®, announced today the completion of the acquisition of Spherix Consulting, Inc., a subsidiary of Spherix, Inc.
Tonja Jimenez is far from the only person driving an RV down Colorado's rural highways. But unlike the other rigs, her 34-foot-long motor home is equipped as an addiction treatment clinic on wheels, bringing lifesaving treatment to the northeastern corner of the state, where patients with substance use disorders are often left to fend for themselves.
› Verified 1 days ago
| Entity Name | Mcalester Medical Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317998 PECOS PAC ID: 9931139029 Enrollment ID: O20050818000234 |
News Archive
NovaBay Pharmaceuticals, Inc. today announced that its lead product candidate was safe and efficacious against the highly contagious skin infection impetigo in a Phase 2a proof-of-concept clinical trial. This dose-ranging study showed that the drug cleared impetigo infections, including those in the trial caused by a drug-resistant strain of bacteria called methicillin-resistant Staphylococcus aureus or MRSA. Impetigo afflicts approximately 1 million people, primarily infants and children, in the United States annually.
In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.
For the first time, researchers led by Frank Lau, MD, Assistant Professor of Clinical Surgery at LSU Health New Orleans, have successfully kept white fat tissue alive outside of the body for up to eight weeks.
ChromaDex Corporation ("ChromaDex"), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure®, announced today the completion of the acquisition of Spherix Consulting, Inc., a subsidiary of Spherix, Inc.
Tonja Jimenez is far from the only person driving an RV down Colorado's rural highways. But unlike the other rigs, her 34-foot-long motor home is equipped as an addiction treatment clinic on wheels, bringing lifesaving treatment to the northeastern corner of the state, where patients with substance use disorders are often left to fend for themselves.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Pritchard, MD 10901 E 48th St, Tulsa, OK 74146-5830 Ph: (918) 749-8765 | Charles Pritchard, MD 10901 E 48th St, Tulsa, OK 74146-5830 Ph: (918) 749-8765 |
News Archive
NovaBay Pharmaceuticals, Inc. today announced that its lead product candidate was safe and efficacious against the highly contagious skin infection impetigo in a Phase 2a proof-of-concept clinical trial. This dose-ranging study showed that the drug cleared impetigo infections, including those in the trial caused by a drug-resistant strain of bacteria called methicillin-resistant Staphylococcus aureus or MRSA. Impetigo afflicts approximately 1 million people, primarily infants and children, in the United States annually.
In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.
For the first time, researchers led by Frank Lau, MD, Assistant Professor of Clinical Surgery at LSU Health New Orleans, have successfully kept white fat tissue alive outside of the body for up to eight weeks.
ChromaDex Corporation ("ChromaDex"), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure®, announced today the completion of the acquisition of Spherix Consulting, Inc., a subsidiary of Spherix, Inc.
Tonja Jimenez is far from the only person driving an RV down Colorado's rural highways. But unlike the other rigs, her 34-foot-long motor home is equipped as an addiction treatment clinic on wheels, bringing lifesaving treatment to the northeastern corner of the state, where patients with substance use disorders are often left to fend for themselves.
› Verified 1 days ago
Dr. Dae Y Kim, M.D., PH.D Urology Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Suite 202, Tulsa, OK 74104 Phone: 918-579-3130 Fax: 918-579-3139 | |
Dr. Clarence Michael Johnson, D.O. Urology Medicare: Not Enrolled in Medicare Practice Location: 802 S Jackson Ave, Suite 110, Tulsa, OK 74127 Phone: 918-599-4477 Fax: 918-599-4479 | |
Bruce Carlton Stoesser, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 10901 E 48th St S, Tulsa, OK 74146 Phone: 918-749-8765 Fax: 918-392-2155 | |
Kevin Joseph Gancarczyk, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10901 E 48th St, Tulsa, OK 74146 Phone: 918-749-8765 Fax: 918-392-2155 | |
Dr. Rustin Chanc Walters, M.D. Urology Medicare: Medicare Enrolled Practice Location: 10901 E 48th St, Tulsa, OK 74146 Phone: 918-749-8765 Fax: 918-392-2155 | |
Jack Steve Miller, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10901 E 48th St, Tulsa, OK 74146 Phone: 918-749-8765 Fax: 918-392-2155 | |
Dr. Paul G Hagood, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Ste 202, Tulsa, OK 74104 Phone: 918-579-3130 Fax: 918-579-3139 |